Skip to main content
Top
Published in: BMC Health Services Research 1/2019

Open Access 01-12-2019 | Research article

Implementation of an interprofessional medication adherence program for chronic patients in community pharmacies: how much does it cost for the provider?

Authors: Clemence Perraudin, Jean-François Locca, Christophe Rossier, Olivier Bugnon, Marie-Paule Schneider

Published in: BMC Health Services Research | Issue 1/2019

Login to get access

Abstract

Background

The implementation of an innovative and sustainable professional pharmacy service in routine care requires substantial resources borne by the pharmacy owner. Although a community pharmacy is a business setting, few studies have examined cost as a potential barrier to widespread implementation. Implementation costs, as the cost impact of an implementation effort, can be significant and hamper the decision to invest from the provider perspective. Traditional financial planning tools can be used to analyse and support business decision to implement a service by assessing the net impact of a new service on the provider’s budget. This study aimed to estimate the implementation costs and the break-even point of an interprofessional medication adherence program for chronic patients in Switzerland. The program combines motivational interviews, medication adherence electronic monitoring and feedback reports to patient and physicians.

Methods

We used a 3-step approach: (i) micro-costing analysis: identification of implementation activities, quantification and valuation of required resources. Implementation costs, including service support costs and direct delivery costs, were analysed according to the implementation phase (installation, initial implementation, and full operation); (ii) break-even analysis: estimation of the required number of patients to follow up with to ensure that the generated revenue exceeded the total cost; and (iii) univariate sensitivity analyses.

Results

The estimated total cost of the installation phase was 8481 CHF, more than half of which represented the cost of the equipment. Direct delivery costs were 666 CHF per patient per year, with 68% of this value associated with the cost of workforce time. According to the Swiss national reimbursement system, a minimal of 16 [10–27] patients was required to cover the implementation costs of the installation phase. This break-even point decreased to 13 patients in the initial and full operation phases.

Conclusions

These estimates lead to a better understanding of the real cost of implementing a professional pharmacy service in routine care. In a Swiss context, the current medication adherence support fee-for-service system allows pharmacists to reach the break-even point. Such information is important for community pharmacists to guide their implementation strategies. The replication of similar analyses in other settings and countries is paramount.
Literature
1.
go back to reference FIP. Centennial Declaration : Improving Global Health by Closing Gaps in the Development, Distribution, and Responsible Use of Medicines2012. FIP. Centennial Declaration : Improving Global Health by Closing Gaps in the Development, Distribution, and Responsible Use of Medicines2012.
2.
go back to reference FIP/WHO J. Guildeines on Good Pharmacy Practice : Standards for quality of pharmacy services2011. FIP/WHO J. Guildeines on Good Pharmacy Practice : Standards for quality of pharmacy services2011.
10.
go back to reference Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT. Paying pharmacists for patient care: A systematic review of remunerated pharmacy clinical care services. Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC. 2014;147(4):209–32. doi:https://doi.org/10.1177/1715163514536678. Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT. Paying pharmacists for patient care: A systematic review of remunerated pharmacy clinical care services. Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC. 2014;147(4):209–32. doi:https://​doi.​org/​10.​1177/​1715163514536678​.
15.
go back to reference Lelubre M, Kamal S, Genre N, Celio J, Gorgerat S, Hugentobler Hampai D et al. Interdisciplinary Medication Adherence Program: The Example of a University Community Pharmacy in Switzerland. BioMed Res Int. 2015;2015:10. doi:https://doi.org/10.1155/2015/103546. Lelubre M, Kamal S, Genre N, Celio J, Gorgerat S, Hugentobler Hampai D et al. Interdisciplinary Medication Adherence Program: The Example of a University Community Pharmacy in Switzerland. BioMed Res Int. 2015;2015:10. doi:https://​doi.​org/​10.​1155/​2015/​103546.
16.
go back to reference Lelubre M. CO, Grosjean M., Amighi K., De Vriese C., Bugnon O., Schneider MP. Implementation study related to an interdisciplinary antiretroviral adherence program for HIV patients in community pharmacies. 20th Annual meeting European Society for Patient Adherence, COMpliance, and Persistence; 17–19 November 2016; Lisbon, Portugal2016. Lelubre M. CO, Grosjean M., Amighi K., De Vriese C., Bugnon O., Schneider MP. Implementation study related to an interdisciplinary antiretroviral adherence program for HIV patients in community pharmacies. 20th Annual meeting European Society for Patient Adherence, COMpliance, and Persistence; 17–19 November 2016; Lisbon, Portugal2016.
17.
go back to reference Bourdin A, Berger J, Schluep M, Bugnon O. Development of a person-centred and integrated-care model for promoting safety and medication adherence among multiple sclerosis patients treated with fingolimod. Mult Scler J. 2013;19(11):247. Bourdin A, Berger J, Schluep M, Bugnon O. Development of a person-centred and integrated-care model for promoting safety and medication adherence among multiple sclerosis patients treated with fingolimod. Mult Scler J. 2013;19(11):247.
18.
go back to reference Bawab N. RC, Perraudin C., Bugnon O. Evaluation of the implementation of an interprofessional type 2 diabetes adherence porgram in Swiss primary care setting. 10th Pharmaceutical Care Network Europe working conference; 1–4 February 2017; Bled, Slovenia2017. Bawab N. RC, Perraudin C., Bugnon O. Evaluation of the implementation of an interprofessional type 2 diabetes adherence porgram in Swiss primary care setting. 10th Pharmaceutical Care Network Europe working conference; 1–4 February 2017; Bled, Slovenia2017.
20.
go back to reference Kamal S, Glass TR, Calmy A, Lecompte MT, Bugnon O, Parienti J-J et al. 145-Does an adherence-enhancing program increase retention in care in the Swiss HIV Cohort? IAPAC; 06.06.2017; Miami,USA2017. Kamal S, Glass TR, Calmy A, Lecompte MT, Bugnon O, Parienti J-J et al. 145-Does an adherence-enhancing program increase retention in care in the Swiss HIV Cohort? IAPAC; 06.06.2017; Miami,USA2017.
21.
go back to reference de Bruin M, Oberjé EJM, Viechtbauer W, Nobel H-E, Hiligsmann M, van Nieuwkoop C, et al. Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial. Lancet Infect Dis. 2017;17(6):595–604. https://doi.org/10.1016/S1473-3099(16)30534-5.CrossRefPubMed de Bruin M, Oberjé EJM, Viechtbauer W, Nobel H-E, Hiligsmann M, van Nieuwkoop C, et al. Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial. Lancet Infect Dis. 2017;17(6):595–604. https://​doi.​org/​10.​1016/​S1473-3099(16)30534-5.CrossRefPubMed
25.
go back to reference Kaae S, Christensen ST. Exploring long term implementation of cognitive services in community pharmacies - a qualitative study. Pharm Pract. 2012;10(3):151–8.CrossRef Kaae S, Christensen ST. Exploring long term implementation of cognitive services in community pharmacies - a qualitative study. Pharm Pract. 2012;10(3):151–8.CrossRef
31.
go back to reference Zarkin G, Bray J, Hinde J, Saitz R. Costs of screening and brief intervention for illicit drug use in primary care settings. J Stud Alcohol and Drugs. 2015;76(2):222–8.CrossRef Zarkin G, Bray J, Hinde J, Saitz R. Costs of screening and brief intervention for illicit drug use in primary care settings. J Stud Alcohol and Drugs. 2015;76(2):222–8.CrossRef
32.
go back to reference Garcia-Cardenas V, Benrimoj SI, Ocampo CC, Goyenechea E, Martinez-Martinez F, Gastelurrutia MA. Evaluation of the implementation process and outcomes of a professional pharmacy service in a community pharmacy setting. A case report. Research in Social and Administrative Pharmacy. 2016. doi:https://doi.org/10.1016/j.sapharm.2016.05.048. Garcia-Cardenas V, Benrimoj SI, Ocampo CC, Goyenechea E, Martinez-Martinez F, Gastelurrutia MA. Evaluation of the implementation process and outcomes of a professional pharmacy service in a community pharmacy setting. A case report. Research in Social and Administrative Pharmacy. 2016. doi:https://​doi.​org/​10.​1016/​j.​sapharm.​2016.​05.​048.
35.
go back to reference Drummond MF, Sculpher MJ, Torrance GW, O'Brien B, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press; 2005. Drummond MF, Sculpher MJ, Torrance GW, O'Brien B, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press; 2005.
36.
go back to reference McBryde-Foster MJ. Break-even analysis in a nurse-managed center. Nursing economic$. 2005;23(1):31–4, 3. McBryde-Foster MJ. Break-even analysis in a nurse-managed center. Nursing economic$. 2005;23(1):31–4, 3.
37.
go back to reference Gold MR, Siegel JE, Russell L, Weinstein M. Cost-effectiveness in health and medicine. New York: NY: Oxford University Press; 1996. Gold MR, Siegel JE, Russell L, Weinstein M. Cost-effectiveness in health and medicine. New York: NY: Oxford University Press; 1996.
38.
go back to reference Sach TH, Desborough J, Houghton J, Holland R. Applying micro-costing methods to estimate the costs of pharmacy interventions: an illustration using multi-professional clinical medication reviews in care homes for older people. The International journal of pharmacy practice. 2014. https://doi.org/10.1111/ijpp.12162. Sach TH, Desborough J, Houghton J, Holland R. Applying micro-costing methods to estimate the costs of pharmacy interventions: an illustration using multi-professional clinical medication reviews in care homes for older people. The International journal of pharmacy practice. 2014. https://​doi.​org/​10.​1111/​ijpp.​12162.
39.
40.
go back to reference Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
41.
go back to reference Niquille A, Lattmann C, Bugnon O. Medication reviews led by community pharmacists in Switzerland: a qualitative survey to evaluate barriers and facilitators. Pharm Pract. 2010;8(1):35–42. Niquille A, Lattmann C, Bugnon O. Medication reviews led by community pharmacists in Switzerland: a qualitative survey to evaluate barriers and facilitators. Pharm Pract. 2010;8(1):35–42.
Metadata
Title
Implementation of an interprofessional medication adherence program for chronic patients in community pharmacies: how much does it cost for the provider?
Authors
Clemence Perraudin
Jean-François Locca
Christophe Rossier
Olivier Bugnon
Marie-Paule Schneider
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2019
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-018-3851-x

Other articles of this Issue 1/2019

BMC Health Services Research 1/2019 Go to the issue